Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
17.03.24
€3.00
31.01.26
60.34%
25.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Inventiva SA

Start price
Target price
Perf. (%)
€3.71
17.03.24
€5.00
31.01.26
-2.70%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€10.20
17.03.24
€16.00
30.06.26
-8.82%
19.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.03.24 60%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
16.03.24
€2.00
16.03.25
2.26%
30.03.24

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Chromadex Corp

Start price
Target price
Perf. (%)
€2.22
16.03.24
€4.00
16.03.25
53.15%
30.03.24

EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€4.89
16.03.24
€48.00
16.03.25
-12.06%
30.03.24

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected
mixitrader 
16.03.24 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.68
12.03.24
-
12.03.25
81.49%
15.03.24

Could be very worthwhile Investment >20% year
Global_Player 
12.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.78
11.03.24
€28.00
11.03.25
6.63%
28.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
11.03.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€64.50
08.03.24
-
08.03.25
-8.53%
15.03.24

Could be worthwhile Investment >10% per year
Global_Player 
08.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
6.69%
06.05.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
05.03.24 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€25.60
04.03.24
-
04.03.25
-0.78%
15.03.24

Risky Investment
michaelkr 
04.03.24 50%
sell
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€4.00
04.03.24
-
04.03.25
-13.00%
16.03.24

Probably not worthwhile Investment
daimler1 
04.03.24 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€83.00
03.03.24
€180.00
31.05.26
-16.27%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
03.03.24 70%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.96
03.03.24
-
03.03.25
10.06%
15.03.24

Could be very worthwhile Investment >20% year
bundfuture 
03.03.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.71
24.02.24
-
24.02.25
-5.26%
02.03.24

Could be worthwhile Investment >10% per year
Global_Player 
24.02.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€13.99
23.02.24
€15.00
23.02.25
4.93%
29.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Well known brand
Traumtanz 
23.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
22.02.24
-
22.02.25
4.52%
02.03.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
22.02.24 0%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.19
22.02.24
-
22.02.25
-10.80%
02.03.24

Nicheplayer
Risky Investment
kostojunior 
22.02.24 0%
sell
Bayer AG

Start price
Target price
Perf. (%)
€28.75
21.02.24
-
21.03.24
-6.87%
11.03.24

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
21.02.24 50%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.86
21.02.24
-
21.02.25
8.94%
02.03.24

Good culture
Probably not worthwhile Investment
No uniques
me8 
21.02.24 0%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
10.34%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
19.02.24
-
19.02.25
2.41%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
19.02.24
-
19.02.25
-24.14%
04.03.24

Risky Investment
robertinio 
19.02.24 0%